Results 101 to 110 of about 5,151 (200)

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO₂TECT Randomized Clinical Trial of ESA-Naïve Patients. [PDF]

Kidney Med, 2023
Winkelmayer WC, Arnold S, Burke SK, Chertow GM, Eckardt KU, Jardine AG, Lewis EF, Luo W, Matsushita K, McCullough PA, Minga T, Parfrey PS.   +11 more
europepmc   +1 more source

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO₂TECT Randomized Clinical Trial of ESA-Treated Patients. [PDF]

Kidney Med, 2023
Parfrey PS, Burke SK, Chertow GM, Eckardt KU, Jardine AG, Lewis EF, Luo W, Matsushita K, McCullough PA, Minga T, Winkelmayer WC.   +10 more
europepmc   +1 more source

Estudio retrospectivo de la influencia de la respuesta al tratamiento quimioterápico de primera línea en pacientes con cáncer no microcítico de pulmón sobre la respuesta a la administración de factores estimulantes de la eritropoyesis en la anemia inducida por quimioterapia [PDF]

, 2012
S'analitza de manera retrospectiva la relació entre la resposta a la quimioteràpia i la milloria de l'anèmia induïda per la quimioteràpia amb factors estimulants de la eritropoesi en 57 pacients amb carcinoma no microcític de pulmó avançat que ...
Blasco Mollá, Sara, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina   +2 more
core  

ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. [PDF]

Int J Hematol, 2022
Morita Y, Nannya Y, Ichikawa M, Hanamoto H, Shibayama H, Maeda Y, Hata T, Miyamoto T, Kawabata H, Takeuchi K, Tanaka H, Kishimoto J, Miyano S, Matsumura I, Ogawa S, Akashi K, Kanakura Y, Mitani K.   +17 more
europepmc   +1 more source

An Exploratory Analysis of Pharmaceutical Price Disparities and Their Implications Among Six Developed Nations [PDF]

In our study of 43 drugs, prescription drug prices in several wealthy nations (Australia, Canada, France, Germany, and the U.K.) were much lower than in the U.S. on average, well below relative per capita GDP. There was relatively little difference among
Calfee, John E., DuPr�, Elizabeth, Villarreal, Mario   +2 more
core   +1 more source

Iron status and erythropoiesis response to darbepoetin alfa in dogs with chronic kidney disease. [PDF]

J Vet Med Sci, 2021
Bhamarasuta C, Premratanachai K, Mongkolpinyopat N, Yothapand P, Vejpattarasiri T, Dissayabutra T, Trisiriroj M, Sutayatram S, Buranakarl C.   +8 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients. [PDF]

Ther Apher Dial, 2021
Akizawa T, Yamaguchi Y, Majikawa Y, Reusch M.   +3 more
europepmc   +1 more source

Darbepoetin Alfa [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

The QUEST initiative anemia study in ESRD: rationale and study protocol [PDF]

, 2007
No ...
Del Vecchio, Lucia, Deska-Slizien, Alicja, Jager, Kitty J., Locatelli, Francesco, Martins Prata, Mateus, Mauri, Joan M., Metsarinne, Kaj, Mircescu, Gabriel, Siamopoulos, Kostas C., Stel, Vianda S., Van Biesen, Wim, Wauters, Jean Pierre, Will, Eric, Zoccali, Carmine   +13 more
core